Egyszerű nézet

dc.contributor.author Madonna R
dc.contributor.author Petrov L
dc.contributor.author Teberino MA
dc.contributor.author Manzoli L
dc.contributor.author Karam JP
dc.contributor.author Renna FV
dc.contributor.author Ferdinandy, Péter
dc.contributor.author Montero-Menei CN
dc.contributor.author Yla-Herttuala S
dc.contributor.author De Caterina R
dc.date.accessioned 2018-09-12T12:04:10Z
dc.date.available 2018-09-12T12:04:10Z
dc.date.issued 2015
dc.identifier 84943368819
dc.identifier.citation pagination=39-49; journalVolume=108; journalIssueNumber=1; journalTitle=CARDIOVASCULAR RESEARCH;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/6205
dc.identifier.uri doi:10.1093/cvr/cvv197
dc.description.abstract RATIONALE: Engraftment and survival of transplanted stem or stromal cells in the microenvironment of host tissues may be improved by combining such cells with scaffolds to delay apoptosis and enhance regenerative properties. OBJECTIVES: We examined whether poly(lactic-co-glycolic acid) (PLGA) pharmacologically active microcarriers (PAMs) releasing vascular endothelial growth factor (VEGF) enhance survival, differentiation and angiogenesis of adipose tissue-mesenchymal stromal cells (AT-MSCs). We analyzed the efficacy of transplanted AT-MSCs conjugated with PAMs in a murine model of acute myocardial infarction (AMI). METHODS: We used fibronectin-coated (empty) PAMs or VEGF-releasing PAMs covered with murine AT-MSCs. Twelve month-old C57 mice underwent coronary artery ligation (Lig) to induce AMI, and were randomized into 5 treatment groups: AMI control (saline 20 microL, n=7), AMI followed by intramyocardial injection with AT-MSCs (2.5x105 cells/20 microL, n=5), or concentrated medium from AT-MSCs (CM, 20 microL, n=8), or AT-MSCs (2.5x105 cells/20 microL) conjugated with empty PAMs (n=7), or VEGF-releasing PAMs (n=8). Sham-operated mice (n=7) were used as controls. RESULTS: VEGF-releasing PAMs increased proliferation and angiogenic potential of AT-MSCs, but did not impact their osteogenic or adipogenic differentiation. AT-MSCs conjugated with VEGF-releasing PAMs inhibited apoptosis, decreased fibrosis, increased arteriogenesis and the number of cardiac-resident Ki-67 positive cells, and improved myocardial fractional shortening compared with AT-MSCs alone when transplanted into the infarcted hearts of C57 mice. With the exception of fractional shortening, all such effects of AT-MSCs conjugated with VEGF-PAMs were paralleled by the injection of CM. CONCLUSIONS: AT-MSCs conjugated with VEGF-releasing PAMs exert paracrine effects that may have therapeutic applications.
dc.relation.ispartof urn:issn:0008-6363
dc.title Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction
dc.type Journal Article
dc.date.updated 2018-08-27T19:04:24Z
dc.language.rfc3066 en
dc.identifier.mtmt 2921642
dc.identifier.wos 000362851400005
dc.identifier.pubmed 26187727
dc.contributor.department SE/AOK/I/Farmakológiai és Farmakoterápiás Intézet
dc.contributor.institution Semmelweis Egyetem


Kapcsolódó fájlok:

A fájl jelenleg csak egyetemi IP címről érhető el.

Megtekintés/Megnyitás

Ez a rekord az alábbi gyűjteményekben szerepel:

Egyszerű nézet